Emel Sabaz Karakeci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emel Sabaz Karakeci has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Nesibe Aydoğdu
Department of Internal Medicine, Fethi Sekin City Hospital, Health Sciences University, Elazig, Türkiye
3 shared publications - Ahmet Karakeci
Department of Urology, Fırat University, Elazığ, Turkey
1 shared publication - Ahmet Karataş
Department of Rheumatology, Faculty of Medicine Firat University Elazig Turkey
1 shared publication - Ahmet Keles
Istanbul Medeniyet University
1 shared publication - Alev İnCe1 shared publication
Arzu Kaya
Department of Physical Medicine and Rehabilitation, Fırat University, Faculty of Medicine, Elazığ, Turkey
1 shared publication
Latest Publications
- 5 November 2026
- Published by Academician Publishing
- p. 105-110
Faz I Yoğun Dekonjestif Faz
- 5 November 2026
- Published by Academician Publishing
Lipödem
- Open Access
- 28 August 2026
- Published by Wiley in American Journal of Human Biology
- Vol. 38 (9) , e70327
Assessment of the 2D : 4D Digit Ratio in Women With Fibromyalgia: Traces of Prenatal Hormonal Exposure
Objectives: Fibromyalgia is a chronic pain syndrome predominantly affecting women, characterized by widespread pain, fatigue, sleep disturbances, and cognitive impairment, yet lacks objective diagnostic biomarkers. The 2D:4D digit ratio is considered an indirect marker of prenatal sex hormone exposure, with lower values reflecting greater fetal androgen influence. This study aimed to evaluate the 2D:4D digit ratio in women with fibromyalgia and assess its potential as a noninvasive biomarker. Methods: Fifty‐seven female fibromyalgia patients (2016 ACR criteria) and 32 age‐matched healthy female controls were enrolled. Index and ring finger lengths were measured bilaterally using digital calipers, and group comparisons were performed with Welch's t ‐test and Mann–Whitney U test. Results: Mean age was comparable between groups ( p = 0.685). Both the right 2D:4D ratio (0.991 ± 0.031 vs. 1.022 ± 0.016; p < 0.001; Cohen's d = −1.18) and the left 2D:4D ratio (0.999 [IQR 0.975–1.023] vs. 1.021 [IQR 1.013–1.034]; p < 0.001; Cohen's d = −0.98) were significantly lower in patients. Conclusion: Women with fibromyalgia exhibit significantly lower 2D:4D digit ratios in both hands compared to healthy controls, with the right hand demonstrating greater discriminative power. These findings suggest an association between digit ratios and fibromyalgia, pointing to potential observational links with prenatal hormonal proxy markers that warrant further mechanistic investigation. The right‐hand 2D:4D ratio is simple, painless, and inexpensive to measure, and might therefore be worth exploring as a potential supportive parameter in future research. Larger multicenter studies are warranted to validate these findings across different populations.
- 28 August 2026
- Published by Wiley in American Journal of Human Biology
- Vol. 38 (9) , e70327
Open AccessAssessment of the 2D : 4D Digit Ratio in Women With Fibromyalgia: Traces of Prenatal Hormonal Exposure
Objectives: Fibromyalgia is a chronic pain syndrome predominantly affecting women, characterized by widespread pain, fatigue, sleep disturbances, and cognitive impairment, yet lacks objective diagnostic biomarkers. The 2D:4D digit ratio is considered an indirect marker of prenatal sex hormone exposure, with lower values reflecting greater fetal androgen influence. This study aimed to evaluate the 2D:4D digit ratio in women with fibromyalgia and assess its potential as a noninvasive biomarker. Methods: Fifty‐seven female fibromyalgia patients (2016 ACR criteria) and 32 age‐matched healthy female controls were enrolled. Index and ring finger lengths were measured bilaterally using digital calipers, and group comparisons were performed with Welch's t ‐test and Mann–Whitney U test. Results: Mean age was comparable between groups ( p = 0.685). Both the right 2D:4D ratio (0.991 ± 0.031 vs. 1.022 ± 0.016; p < 0.001; Cohen's d = −1.18) and the left 2D:4D ratio (0.999 [IQR 0.975–1.023] vs. 1.021 [IQR 1.013–1.034]; p < 0.001; Cohen's d = −0.98) were significantly lower in patients. Conclusion: Women with fibromyalgia exhibit significantly lower 2D:4D digit ratios in both hands compared to healthy controls, with the right hand demonstrating greater discriminative power. These findings suggest an association between digit ratios and fibromyalgia, pointing to potential observational links with prenatal hormonal proxy markers that warrant further mechanistic investigation. The right‐hand 2D:4D ratio is simple, painless, and inexpensive to measure, and might therefore be worth exploring as a potential supportive parameter in future research. Larger multicenter studies are warranted to validate these findings across different populations.
- 29 July 2026
- Published by Caleo in Rheumatology Quarterly
Diagnostic Value of Ratios Based on Red Cell Distribution Width in Fibromyalgia: A Case-Control Study
Objective: This study aimed to investigate the relationship between fibromyalgia syndrome (FMS) and inflammatory indices, specifically the red cell distribution width (RDW)-to-albumin ratio (RAR), RDW-to-monocyte ratio (RMR), and RDW-to-lymphocyte ratio (RLR). Methods: A retrospective study was performed with 187 FMS patients and 195 healthy controls. Complete blood count and biochemical parameters were analyzed. Red cell distribution width-to-albumin ratio, RMR, and RLR indices were calculated and compared between the groups. Results: No statistically significant differences were found between the FMS group and the control group for RAR, RMR, and RLR indices (P > .05). Although some parameters like monocyte counts and vitamin D level showed variation, the composite indices did not reach statistical significance. Conclusion: The findings suggest that RAR, RMR, and RLR indices do not have diagnostic value for FMS, potentially due to the low-grade inflammatory nature of the disease. However, more definitive conclusions on this matter require prospective, advanced clinical trials with larger sample sizes.
- 29 July 2026
- Published by Caleo in Rheumatology Quarterly
Diagnostic Value of Ratios Based on Red Cell Distribution Width in Fibromyalgia: A Case-Control Study
Objective: This study aimed to investigate the relationship between fibromyalgia syndrome (FMS) and inflammatory indices, specifically the red cell distribution width (RDW)-to-albumin ratio (RAR), RDW-to-monocyte ratio (RMR), and RDW-to-lymphocyte ratio (RLR). Methods: A retrospective study was performed with 187 FMS patients and 195 healthy controls. Complete blood count and biochemical parameters were analyzed. Red cell distribution width-to-albumin ratio, RMR, and RLR indices were calculated and compared between the groups. Results: No statistically significant differences were found between the FMS group and the control group for RAR, RMR, and RLR indices (P > .05). Although some parameters like monocyte counts and vitamin D level showed variation, the composite indices did not reach statistical significance. Conclusion: The findings suggest that RAR, RMR, and RLR indices do not have diagnostic value for FMS, potentially due to the low-grade inflammatory nature of the disease. However, more definitive conclusions on this matter require prospective, advanced clinical trials with larger sample sizes.
- Open Access
- 10 June 2026
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 72 (2) , 207-215
The association between visceral fat indices and diabetic peripheral neuropathy in type 2 diabetes mellitus: A retrospective cross-sectional study
Objectives: The research investigates how type 2 diabetes mellitus (T2DM) patients with diabetic peripheral neuropathy (DPN) relate to their visceral fat indices, which include visceral adiposity index, lipid accumulation product, and atherogenic plasma index (AIP). Patients and methods: The retrospective study analyzed 562 T2DM patients (324 females, 238 males; mean age: 64±13.3 years; range, 56 to 72 years) between January 2022 and December 2024. Participants were divided into two groups based on their electromyography (EMG) results and Leeds Assessment of Neuropathic Symptoms and Signs pain scale scores (a score of 12 or higher indicated neuropathy). Electromyography-positive patients (n=213) were compared with EMG-negative patients (n=349) for their anthropometric data, biochemical results, and visceral fat measurements. Independent factors that predicted DPN were sought to be identified. Results: The EMG-positive patients showed higher values for body mass index, visceral adiposity index, lipid accumulation product, and AIP, as well as triglycerides and hemoglobin A1c levels, compared to EMG-negative patients (p<0.001 and p<0.01). The logistic regression analysis revealed that hemoglobin levels (odds ratio =0.83, 95% confidence interval 0.74-0.94), hemoglobin A1c levels, waist circumference, and AIP served as independent risk factors for DPN. Conclusion: The findings show that visceral fat indices serve as effective biomarkers in identifying T2DM patients at high risk of developing DPN. The combination of these indices with glycemic control monitoring could improve DPN prevention methods. Future research needs to conduct bigger prospective studies to confirm these findings and understand the intricate links between lipid metabolism, visceral fat, and DPN.
- 10 June 2026
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 72 (2) , 207-215
Open AccessThe association between visceral fat indices and diabetic peripheral neuropathy in type 2 diabetes mellitus: A retrospective cross-sectional study
Objectives: The research investigates how type 2 diabetes mellitus (T2DM) patients with diabetic peripheral neuropathy (DPN) relate to their visceral fat indices, which include visceral adiposity index, lipid accumulation product, and atherogenic plasma index (AIP). Patients and methods: The retrospective study analyzed 562 T2DM patients (324 females, 238 males; mean age: 64±13.3 years; range, 56 to 72 years) between January 2022 and December 2024. Participants were divided into two groups based on their electromyography (EMG) results and Leeds Assessment of Neuropathic Symptoms and Signs pain scale scores (a score of 12 or higher indicated neuropathy). Electromyography-positive patients (n=213) were compared with EMG-negative patients (n=349) for their anthropometric data, biochemical results, and visceral fat measurements. Independent factors that predicted DPN were sought to be identified. Results: The EMG-positive patients showed higher values for body mass index, visceral adiposity index, lipid accumulation product, and AIP, as well as triglycerides and hemoglobin A1c levels, compared to EMG-negative patients (p<0.001 and p<0.01). The logistic regression analysis revealed that hemoglobin levels (odds ratio =0.83, 95% confidence interval 0.74-0.94), hemoglobin A1c levels, waist circumference, and AIP served as independent risk factors for DPN. Conclusion: The findings show that visceral fat indices serve as effective biomarkers in identifying T2DM patients at high risk of developing DPN. The combination of these indices with glycemic control monitoring could improve DPN prevention methods. Future research needs to conduct bigger prospective studies to confirm these findings and understand the intricate links between lipid metabolism, visceral fat, and DPN.
- Open Access
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (1)
ROLES OF THE C‐REACTIVE PROTEIN‐ALBUMIN‐LYMPHOCYTE INDEX AND PAN-IMMUNE-INFLAMMATION VALUE INDICES AS NEW INDICATORS OF DEMENTIA SEVERITY
Introduction: Alzheimer’s disease is a common condition that can be challenging to diagnose, primarily due to the high costs and limited availability of specific tests. This study aimed to explore the relationship between peripheral inflammation markers, such as pan-immune-inflammation-value and the C-reactive protein -albumin-lymphocyte and their ability to predict the severity of the disease. Materials and Method: A total of 232 patients diagnosed with Alzheimer’stype dementia and 52 healthy individuals with no history of the disease were retrospectively included in the study conducted between January 2024 and November 2025. The patients were classified into five groups based on the Clinical Dementia Rating Scale. After a 10-12 hour fast, venous blood samples were collected from all participants, and demographic and clinical data were obtained from the hospital information system. The analysis included complete blood count parameters (leukocytes, neutrophils, lymphocytes, monocytes, and platelets), C-reactive protein levels, serum albumin levels, and routine biochemical parameters from the blood samples. Results: Although there was no significant difference in pan-immuneinflammation values between the study groups (p = 0.721), the C-reactive protein-albumin-lymphocyte index showed a significant decrease as the severity of dementia increased. Similarly, Albumin-Lymphocyte Ratio, Systemic Inflammatory Index, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio also showed significant differences between the groups (p < 0.05). Conclusion: The findings of this study highlight the attractiveness of the C-reactive protein-albumin-lymphocyte index and the albumin/lymphocyte ratio as potential screening tools for dementia risk assessment in clinical settings. Keywords: Biomarkers; C-Reactive Protein; Lymphocytes; Prognosis; Dementia; Inflammation; Retrospective Studies.
- 1 January 2026
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 29 (1)
Open AccessROLES OF THE C‐REACTIVE PROTEIN‐ALBUMIN‐LYMPHOCYTE INDEX AND PAN-IMMUNE-INFLAMMATION VALUE INDICES AS NEW INDICATORS OF DEMENTIA SEVERITY
Introduction: Alzheimer’s disease is a common condition that can be challenging to diagnose, primarily due to the high costs and limited availability of specific tests. This study aimed to explore the relationship between peripheral inflammation markers, such as pan-immune-inflammation-value and the C-reactive protein -albumin-lymphocyte and their ability to predict the severity of the disease. Materials and Method: A total of 232 patients diagnosed with Alzheimer’stype dementia and 52 healthy individuals with no history of the disease were retrospectively included in the study conducted between January 2024 and November 2025. The patients were classified into five groups based on the Clinical Dementia Rating Scale. After a 10-12 hour fast, venous blood samples were collected from all participants, and demographic and clinical data were obtained from the hospital information system. The analysis included complete blood count parameters (leukocytes, neutrophils, lymphocytes, monocytes, and platelets), C-reactive protein levels, serum albumin levels, and routine biochemical parameters from the blood samples. Results: Although there was no significant difference in pan-immuneinflammation values between the study groups (p = 0.721), the C-reactive protein-albumin-lymphocyte index showed a significant decrease as the severity of dementia increased. Similarly, Albumin-Lymphocyte Ratio, Systemic Inflammatory Index, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio also showed significant differences between the groups (p < 0.05). Conclusion: The findings of this study highlight the attractiveness of the C-reactive protein-albumin-lymphocyte index and the albumin/lymphocyte ratio as potential screening tools for dementia risk assessment in clinical settings. Keywords: Biomarkers; C-Reactive Protein; Lymphocytes; Prognosis; Dementia; Inflammation; Retrospective Studies.
- 4 December 2025
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. 36 (1)
Effects of N–acetyl cysteine on serum podocalyxin and pentraxin levels in an experimental lower extremity ischemia–reperfusion injury model
Ischemia–reperfusion injury causes oxidative stress and inflammation, leading to skeletal muscle damage. This study investigates the role of N–acetylcysteine in modulating oxidative stress and inflammatory biomarkers specifically Podocalyxin and Pentraxin 3 in a rat model of lower extremity Ischemia–reperfusion injury. An experimental, controlled animal study conducted at the Experimental Research Center of Firat University. Twenty–four female Sprague–Dawley rats were allocated into four groups: control, sham, Ischemia–reperfusion, and Ischemia–reperfusion treated with N–acetylcysteine. Ischemia was induced by clamping the infrarenal abdominal aorta for 120 min, followed by 120 min of reperfusion. A single dose of N–acetylcysteine (150 mg·kg-1, i.p.) was administered at the onset of reperfusion in the treatment group. Levels of serum Total Oxidative Status and Total Antioxidant Status, as well as the expression of Podocalyxin and Pentraxin 3 in tissue, were evaluated. A significant increase in Oxidative Status levels and a significant decrease in Antioxidant Status levels were observed in the Ischemia–reperfusion group compared to the control group. After administering N–acetylcysteine, there was a significant decrease in Oxidative Status levels and a significant increase in Antioxidant Status levels when compared to the Ischemia–reperfusion group. Histological evaluation showed that N–acetylcysteine reduced edema, hemorrhage, and overall tissue injury scores. Immunohistochemical analyses revealed increased Podocalyxin and Pentraxin 3 expression in Ischemia– reperfusion group tissues, which was notably diminished in the N–acetylcysteine – treated group. N–acetylcysteine demonstrated protective effects against Ischemia–reperfusion–induced oxidative and inflammatory damage in skeletal muscle by reducing serum and tissue levels of Podocalyxin and Pentraxin 3. These findings suggest its therapeutic potential in mitigating Ischemia– reperfusion injury and highlight Podocalyxin and Pentraxin 3 as promising biomarkers for tissue damage and treatment monitoring.
- 4 December 2025
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. 36 (1)
Effects of N–acetyl cysteine on serum podocalyxin and pentraxin levels in an experimental lower extremity ischemia–reperfusion injury model
Ischemia–reperfusion injury causes oxidative stress and inflammation, leading to skeletal muscle damage. This study investigates the role of N–acetylcysteine in modulating oxidative stress and inflammatory biomarkers specifically Podocalyxin and Pentraxin 3 in a rat model of lower extremity Ischemia–reperfusion injury. An experimental, controlled animal study conducted at the Experimental Research Center of Firat University. Twenty–four female Sprague–Dawley rats were allocated into four groups: control, sham, Ischemia–reperfusion, and Ischemia–reperfusion treated with N–acetylcysteine. Ischemia was induced by clamping the infrarenal abdominal aorta for 120 min, followed by 120 min of reperfusion. A single dose of N–acetylcysteine (150 mg·kg-1, i.p.) was administered at the onset of reperfusion in the treatment group. Levels of serum Total Oxidative Status and Total Antioxidant Status, as well as the expression of Podocalyxin and Pentraxin 3 in tissue, were evaluated. A significant increase in Oxidative Status levels and a significant decrease in Antioxidant Status levels were observed in the Ischemia–reperfusion group compared to the control group. After administering N–acetylcysteine, there was a significant decrease in Oxidative Status levels and a significant increase in Antioxidant Status levels when compared to the Ischemia–reperfusion group. Histological evaluation showed that N–acetylcysteine reduced edema, hemorrhage, and overall tissue injury scores. Immunohistochemical analyses revealed increased Podocalyxin and Pentraxin 3 expression in Ischemia– reperfusion group tissues, which was notably diminished in the N–acetylcysteine – treated group. N–acetylcysteine demonstrated protective effects against Ischemia–reperfusion–induced oxidative and inflammatory damage in skeletal muscle by reducing serum and tissue levels of Podocalyxin and Pentraxin 3. These findings suggest its therapeutic potential in mitigating Ischemia– reperfusion injury and highlight Podocalyxin and Pentraxin 3 as promising biomarkers for tissue damage and treatment monitoring.
- Open Access
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Evaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Open AccessEvaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.
- Open Access
- 30 June 2018
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 33 (2) , 213-220
Association of the Commitments and Responsibilities of the Caregiver Within the Family to the Disease Activity in Patients With Rheumatoid Arthritis: A Report From Turkey
Objectives: This study aims to investigate the commitments and responsibilities of the family caregiver of rheumatoid arthritis patients and determine the association of these to the disease activity. Patients and methods: The study included a total of 240 subjects, consisting of 60 rheumatoid arthritis patients (8 males, 52 females; mean age 50.4±11.1 years; range 25 to 76 years) with their respective 60 primary caregivers (42 males, 18 females; mean age 43.1±15.3 years; range 12 to 77 years) and 60 OA patients (7 males, 53 females; mean age 62.8±9.0 years; range 45 to 85 years) with their respective 60 primary caregivers (38 males, 22 females; mean age 47.6±13.2 years; range 27 to 87 years). Disease severity and pain of patients were assessed through visual analog scale. Sedimentation and C-reactive protein values were recorded during routine visits. Patients were stratified by disease activity that was determined by disease activity score-28. Caregivers of patients evaluated disease severity and pain by visual analog scale, and completed Caregiver Reaction Assessment (CRA) and Caregiver Strain Index questionnaires. For a more objective assessment, tasks related to care, household, and assistance and allocated time periods for each group of tasks were queried. Results: When CRA and Caregiver Strain Index were compared in terms of disease activity, patients significantly differed in impact on schedule subscale of CRA (p
- 30 June 2018
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 33 (2) , 213-220
Open AccessAssociation of the Commitments and Responsibilities of the Caregiver Within the Family to the Disease Activity in Patients With Rheumatoid Arthritis: A Report From Turkey
Objectives: This study aims to investigate the commitments and responsibilities of the family caregiver of rheumatoid arthritis patients and determine the association of these to the disease activity. Patients and methods: The study included a total of 240 subjects, consisting of 60 rheumatoid arthritis patients (8 males, 52 females; mean age 50.4±11.1 years; range 25 to 76 years) with their respective 60 primary caregivers (42 males, 18 females; mean age 43.1±15.3 years; range 12 to 77 years) and 60 OA patients (7 males, 53 females; mean age 62.8±9.0 years; range 45 to 85 years) with their respective 60 primary caregivers (38 males, 22 females; mean age 47.6±13.2 years; range 27 to 87 years). Disease severity and pain of patients were assessed through visual analog scale. Sedimentation and C-reactive protein values were recorded during routine visits. Patients were stratified by disease activity that was determined by disease activity score-28. Caregivers of patients evaluated disease severity and pain by visual analog scale, and completed Caregiver Reaction Assessment (CRA) and Caregiver Strain Index questionnaires. For a more objective assessment, tasks related to care, household, and assistance and allocated time periods for each group of tasks were queried. Results: When CRA and Caregiver Strain Index were compared in terms of disease activity, patients significantly differed in impact on schedule subscale of CRA (p